Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial

Controlled Clinical Trials - Tập 21 - Trang 349S-355S - 2000
Richard B. Hayes1, Douglas Reding2, William Kopp3, Amy F. Subar4, Narayan Bhat1, Nathaniel Rothman1, Neil Caporaso1, Regina G. Ziegler1, Christine Cole Johnson5, Joel L. Weissfeld6, Robert N. Hoover1, Patricia Hartge1, Cindy Palace7, John K. Gohagan8
1Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland U.S.A.
2Marshfield Medical Research and Education Foundation, Marshfield, WisconsinU.S.A.
3Scientific Applications International Corporation, Frederick, MarylandU.S.A.
4Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MarylandU.S.A.
5Henry Ford Health System, Detroit, MichiganU.S.A.
6University of Pittsburgh Cancer Institute, Pittsburgh, PennsylvaniaU.S.A.
7Westat, Inc., Rockville, MarylandU.S.A.
8Early Detection Research Group, Division of Cancer Prevention, National Cancer Institute, Bethesda, MarylandU.S.A.

Tài liệu tham khảo

Breslow, 1987 Perera, 1996, Molecular epidemiology in cancer prevention, 101 1997 Gohagan, 2000, The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: History, organization, and status, Control Clin Trials, 21, 251S, 10.1016/S0197-2456(00)00097-0 O'Brien, 2000, Coordination and management of a large multicenter screening trial: The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial, Control Clin Trials, 21, 310S, 10.1016/S0197-2456(00)00099-4 Lum, 1998, A simple mouthwash method for obtaining genomic DNA in molecular epidemiologic studies, Cancer Epidemiology Biomarkers Prev, 7, 719
Thông tin
Thông tin xuất bản

Controlled Clinical Trials

Tập 21

349S-355S

Thông tin tác giả